Elite Pharmaceuticals, Inc. (OTC:ELTP) Q2 2026 Earnings Call Transcript November 17, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Second Quarter of ...

Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Second Quarter of Fiscal Year 2026 Conference Call. [Operator Instructions] Before management begins speaking, the ...

Elite Pharmaceuticals ( (ELTP)) has provided an announcement. Elite Pharmaceuticals announced that it will release its second quarter financial results for the fiscal year 2026 on November 14, 2025, ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Elite ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Total Revenue: $84 million for fiscal year 2025, a 52% increase from $56.6 million in fiscal year 2024. Operating Income: $19.6 million, an 82% increase from $10.8 million in fiscal year 2024.

Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Conference Call. [Operator Instructions] Before management begins speaking, the conference has the following statement.

Shares of Elite Pharmaceuticals, Inc. ELTP have lost 3.3% since the company reported its earnings for the quarter ended Dec. 31, 2024. This compares to the S&P 500 Index’s 1.2% gain over the same time ...